RATIONALE: Children are an at-risk population for developing complications following influenza infection, but immunologic correlates of disease severity are not understood. We hypothesized that innate cellular immune responses at the site of infection would correlate with disease outcome. OBJECTIVES: To test the immunologic basis of severe illness during natural influenza virus infection of children and adults at the site of infection. METHODS: An observational cohort study with longitudinal sampling of peripheral and mucosal sites in 84 naturally influenza-infected individuals, including infants. Cellular responses, viral loads, and cytokines were quantified from nasal lavages and blood, and correlated to clinical severity. MEASUREMENTS AND MAIN RESULTS: We show for the first time that although viral loads in children and adults were similar, innate responses in the airways were stronger in children and varied considerably between plasma and site of infection. Adjusting for age and viral load, an innate immune profile characterized by increased nasal lavage monocyte chemotactic protein-3, IFN-α2, and plasma IL-10 levels at enrollment predicted progression to severe disease. Increased plasma IL-10, monocyte chemotactic protein-3, and IL-6 levels predicted hospitalization. This inflammatory cytokine production correlated significantly with monocyte localization from the blood to the site of infection, with conventional monocytes positively correlating with inflammation. Increased frequencies of CD14(lo) monocytes were in the airways of participants with lower inflammatory cytokine levels. CONCLUSIONS: An innate profile was identified that correlated with disease progression independent of viral dynamics and age. The airways and blood displayed dramatically different immune profiles emphasizing the importance of cellular migration and localized immune phenotypes.
RATIONALE: Children are an at-risk population for developing complications following influenza infection, but immunologic correlates of disease severity are not understood. We hypothesized that innate cellular immune responses at the site of infection would correlate with disease outcome. OBJECTIVES: To test the immunologic basis of severe illness during natural influenza virusinfection of children and adults at the site of infection. METHODS: An observational cohort study with longitudinal sampling of peripheral and mucosal sites in 84 naturally influenza-infected individuals, including infants. Cellular responses, viral loads, and cytokines were quantified from nasal lavages and blood, and correlated to clinical severity. MEASUREMENTS AND MAIN RESULTS: We show for the first time that although viral loads in children and adults were similar, innate responses in the airways were stronger in children and varied considerably between plasma and site of infection. Adjusting for age and viral load, an innate immune profile characterized by increased nasal lavage monocyte chemotactic protein-3, IFN-α2, and plasma IL-10 levels at enrollment predicted progression to severe disease. Increased plasma IL-10, monocyte chemotactic protein-3, and IL-6 levels predicted hospitalization. This inflammatory cytokine production correlated significantly with monocyte localization from the blood to the site of infection, with conventional monocytes positively correlating with inflammation. Increased frequencies of CD14(lo) monocytes were in the airways of participants with lower inflammatory cytokine levels. CONCLUSIONS: An innate profile was identified that correlated with disease progression independent of viral dynamics and age. The airways and blood displayed dramatically different immune profiles emphasizing the importance of cellular migration and localized immune phenotypes.
Authors: Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu Journal: Nat Med Date: 2012-01-29 Impact factor: 53.440
Authors: Nelson Lee; Paul K S Chan; Chun Kwok Wong; Ka-Tak Wong; Kin-Wing Choi; Gavin M Joynt; Philip Lam; Martin C W Chan; Bonnie C K Wong; Grace C Y Lui; Winnie W Y Sin; Rity Y K Wong; Wai-Yip Lam; Apple C M Yeung; Ting-Fan Leung; Hing-Yu So; Alex W Y Yu; Joseph J Y Sung; David S C Hui Journal: Antivir Ther Date: 2011
Authors: Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp Journal: Immunity Date: 2011-02-25 Impact factor: 31.745
Authors: Aaron R Everitt; Simon Clare; Thomas Pertel; Sinu P John; Rachael S Wash; Sarah E Smith; Christopher R Chin; Eric M Feeley; Jennifer S Sims; David J Adams; Helen M Wise; Leanne Kane; David Goulding; Paul Digard; Verneri Anttila; J Kenneth Baillie; Tim S Walsh; David A Hume; Aarno Palotie; Yali Xue; Vincenza Colonna; Chris Tyler-Smith; Jake Dunning; Stephen B Gordon; Rosalind L Smyth; Peter J Openshaw; Gordon Dougan; Abraham L Brass; Paul Kellam Journal: Nature Date: 2012-03-25 Impact factor: 49.962
Authors: Nelson Lee; Chun Kwok Wong; Paul K S Chan; Martin C W Chan; Rity Y K Wong; Samantha W M Lun; Karry L K Ngai; Grace C Y Lui; Bonnie C K Wong; Sharon K W Lee; Kin Wing Choi; David S C Hui Journal: PLoS One Date: 2011-10-13 Impact factor: 3.240
Authors: Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska Journal: Crit Care Date: 2010-11-09 Impact factor: 9.097
Authors: Tim Flerlage; Aisha Souquette; E Kaitlynn Allen; Timothy Brahm; Jeremy Chase Crawford; Li Tang; Yilun Sun; Gabriela Maron; Joshua Wolf; Brandon Triplett; Paul G Thomas Journal: Am J Respir Cell Mol Biol Date: 2020-09 Impact factor: 6.914
Authors: E Kaitlynn Allen; Adrienne G Randolph; Tushar Bhangale; Pranay Dogra; Maikke Ohlson; Christine M Oshansky; Anthony E Zamora; John P Shannon; David Finkelstein; Amy Dressen; John DeVincenzo; Miguela Caniza; Ben Youngblood; Carrie M Rosenberger; Paul G Thomas Journal: Nat Med Date: 2017-07-17 Impact factor: 53.440
Authors: Jackson S Turner; Tingting Lei; Aaron J Schmitz; Aaron Day; José Alberto Choreño-Parra; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Stacey L House; Joaquín Zúñiga; Ali H Ellebedy; Philip A Mudd Journal: J Infect Dis Date: 2020-09-01 Impact factor: 5.226
Authors: Adrienne G Randolph; Wai-Ki Yip; Emma Kaitlynn Allen; Carrie M Rosenberger; Anna A Agan; Stephanie A Ash; Yu Zhang; Tushar R Bhangale; David Finkelstein; Natalie Z Cvijanovich; Peter M Mourani; Mark W Hall; Helen C Su; Paul G Thomas Journal: J Infect Dis Date: 2017-07-01 Impact factor: 5.226
Authors: Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen Journal: Am J Respir Crit Care Med Date: 2016-08-01 Impact factor: 21.405
Authors: Candice C Clay; J Rachel Reader; Joan E Gerriets; Theodore T Wang; Kevin S Harrod; Lisa A Miller Journal: J Virol Date: 2014-04-16 Impact factor: 5.103